April 19, 2025 10:27 AM
Global biopharma IPOs surge to $8.52 billion in 2024 amid market rebound
The global biopharmaceutical sector witnessed a sharp rebound in 2024, with initial public offerings (IPOs) rising by 68.4 per cent to reach $8.52 billion, according to a new report by GlobalData. A total of 50 IPOs were completed during the yea...
